- Home
- MEC vs FULC Comparison
MEC vs FULC Comparison
Compare MEC & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEC
- FULC
- Stock Information
- Founded
- MEC 1945
- FULC 2015
- Country
- MEC United States
- FULC United States
- Employees
- MEC N/A
- FULC N/A
- Industry
- MEC Industrial Specialties
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- MEC Industrials
- FULC Health Care
- Exchange
- MEC Nasdaq
- FULC Nasdaq
- Market Cap
- MEC 329.4M
- FULC 372.2M
- IPO Year
- MEC 2019
- FULC 2019
- Fundamental
- Price
- MEC $14.89
- FULC $7.66
- Analyst Decision
- MEC Strong Buy
- FULC Buy
- Analyst Count
- MEC 3
- FULC 8
- Target Price
- MEC $21.33
- FULC $7.13
- AVG Volume (30 Days)
- MEC 129.0K
- FULC 411.3K
- Earning Date
- MEC 11-04-2025
- FULC 07-29-2025
- Dividend Yield
- MEC N/A
- FULC N/A
- EPS Growth
- MEC 64.18
- FULC N/A
- EPS
- MEC 0.86
- FULC N/A
- Revenue
- MEC $524,606,000.00
- FULC N/A
- Revenue This Year
- MEC N/A
- FULC N/A
- Revenue Next Year
- MEC $17.38
- FULC N/A
- P/E Ratio
- MEC $17.38
- FULC N/A
- Revenue Growth
- MEC N/A
- FULC 2752.05
- 52 Week Low
- MEC $11.72
- FULC $2.32
- 52 Week High
- MEC $23.02
- FULC $9.30
- Technical
- Relative Strength Index (RSI)
- MEC 51.97
- FULC 64.62
- Support Level
- MEC $14.00
- FULC $6.35
- Resistance Level
- MEC $14.75
- FULC $6.75
- Average True Range (ATR)
- MEC 0.38
- FULC 0.39
- MACD
- MEC 0.08
- FULC 0.10
- Stochastic Oscillator
- MEC 97.16
- FULC 86.18
About MEC Mayville Engineering Company Inc.
Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.